Investor Spotlight: Emerillon Capital

Add this event to your calendar:
04/05/2017 12:30 04/05/2017 15:00 America/Toronto Investor Spotlight: Emerillon Capital JLABS @ Toronto , 661 University Ave , Toronto , ON M5G 1M1 JLABS @ Toronto false DD/MM/YYYY

Investor Spotlight: Emerillon Capital

JLABS @ Toronto , 661 University Ave , Toronto , ON M5G 1M1

May 04, 2017 from 12:30 PM to 15:00 PM (EST)

$10 - $35

Are you looking for a partner who can adapt to your venture project?

On May 4th, JLABS @ Toronto invites Emerillon Capital Investment Director, Nicola Urbani, to our “Investor Spotlight” to discuss:

  • Practical tips on what he looks for in a pitch
  • Emerillon Capital’s areas of interest – what are they investing in?
  • Case studies of successful investments
  • How to increase your chances of successful fundraising

Launched in Montreal in June 2013, Emerillon Capital (backed by its lead financial sponsor CM-CIC Investissement) is a venture capital fund with a patient capital and flexible approach. It is dedicated to supporting and investing in companies positioned in expanding sectors showing strong potential for growth. Emerillon is specialized in equity (or quasi-equity) investments and support of companies with strong technological expertise in their early development phases: pre-revenue, commercial start-up and first expansion.

If interested in meeting one-on-one with Nicola after his presentation, please fill out an application here:

10:30 AM | Registration and Networking
11:00 AM | Presentation and Q&A
12:00 PM | Networking and Lunch
12:30 PM - 5:00 PM | One-on-one Meetings*

*Companies must have applied for a one-on-one meeting ahead of time and be approved. The application period ends on April 13, 2017.

$15 | General Public
Includes presentation, Q&A, and lunch. All attendees must pay this fee, regardless of one-on-one meeting status. Pre-registration to attend the presentation, Q&A, and lunch will remain open until noon on May 3rd (or sold out).

JLABS @ Toronto
661 University Ave, Suite 1300
Toronto, Ontario

Nicola Urbani | Investment Director, Emerillon Capital
A management and investment professional with a passion for innovation and broad experience (13 years) in venture capital investment in life sciences and cleantech industries. Worked in two different venture capital Fund managers with a total committed capital of over $400M: GeneChem management (with 4 different Funds targeting different stages and indications: GeneChem Technologies, GeneChem Therapeutics, AgeChem Financial, and AmorChem Financial) and Emerillon Capital. Served on numerous Boards and helped shape company strategies, C-level management teams and Board committees. Active involvement in the growth of several companies developing therapeutics through human clinical trials, and participated in numerous financing rounds with top tier Canadian and international venture capital Funds. Led several in-and out-licensing deals in life sciences and cleantech.
Immediately prior to joining Emerillon, Nicola was VP Commercialization at the McGill-affiliated Jewish General Hospital in Montreal, where he was responsible for technology transfer and the creation of companies. Nicola has a PhD in molecular genetics from McGill University and an MBA from Université du Québec à Montréal.
Connect with Nicola:   Connect on LinkedIn

JLABS @ Toronto

About Johnson & Johnson Innovation, JLABS Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and healthtech sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to ten global locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto, Beerse (Belgium), with New York City, opening in June 2018, and Shanghai in 2019. For more information please visit or follow @JLABS. About Johnson & Johnson Innovation Johnson & Johnson Innovation focuses on accelerating all stages of innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and consumer companies of Johnson & Johnson. Under the Johnson & Johnson Innovation umbrella of businesses, we connect with innovators through our regional Innovation Centers, Johnson & Johnson Innovation | JLABS, Johnson & Johnson Innovation - JJDC, and our Business Development teams to create customized deals and novel collaborations that speed development of innovations to solve unmet needs in patients. For more information please visit or follow @JNJInnovation.

Event contact

Related content